Mitochondrial markers of neurodegenerative diseases
US12065702B2 · kind B2 · utility
0Cited by
0References
12Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 2, 2021 |
| Grant date | Aug 20, 2024 |
| Priority date | — |
| Expiry date | Jun 2, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2600/156
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present invention relates to an in vitro method to diagnose or determine the risk of developing a neurodegenerative disease in a subject based on the determination of the methylation pattern in certain regions of mitochondrial DNA from the subject. Finally, the present invention relates to nucleic acids suitable for application of the invention.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.